Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.

Kyaw Zin Thein Sarina A Piha-Paul Apostolia Tsimberidou Daniel D Karp Filip Janku Abdulrazzak Zarifa Jatin Shah Denái R Milton Stacie Bean Lacey McQuinn Jing Gong Rivka Colen Brett W Carter Vivek Subbiah Deby C Ogbonna Shubham Pant Funda Meric-Bernstam Aung Naing

Invest New Drugs

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

Published: April 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993725	PMC
http://dx.doi.org/10.1007/s10637-021-01192-5	DOI Listing

Publication Analysis

Top Keywords

correction selinexor

selinexor combination

combination topotecan

topotecan patients

patients advanced

advanced metastatic

metastatic solid

solid tumors

tumors open-label

open-label single-center

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!